The following groups are recommended to receive hepatitis B vaccine because of their increased risk of infection through blood products:15
people with clotting disorders who receive blood product concentrates
people with recurrent transfusion requirements
people with underlying immunocompromising conditions who receive blood products
All blood donors in Australia are screened for hepatitis B using tests for hepatitis B surface antigen and nucleic acid amplification. This has greatly decreased the incidence of transfusion-related hepatitis B virusinfection.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.